Mississauga, Canada

Krishna Kumar Gnanasekaran

USPTO Granted Patents = 6 

Average Co-Inventor Count = 4.9

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
6 patents (USPTO):

Title: Innovations of Krishna Kumar Gnanasekaran

Introduction

Krishna Kumar Gnanasekaran is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of bioengineering, particularly in the development of methods to combat bacterial infections. With a total of 6 patents to his name, Gnanasekaran's work has the potential to impact healthcare positively.

Latest Patents

Among his latest patents is the invention titled "Use of small molecule inhibitors of the BfrB:Bfd interaction in biofilms." This invention discloses methods for inhibiting biofilm formation, enhancing bacteriocidal activity within a biofilm, and treating bacteria within a biofilm. Another significant patent is "Small molecule inhibitors of the BfrB:Bfd interaction," which provides compounds and methods for treating bacterial infections and inhibiting the interaction between bacterioferritin and bacterioferritin-associated ferredoxin.

Career Highlights

Gnanasekaran has worked at prestigious institutions such as Oklahoma State University and Louisiana State University and Agricultural & Mechanical College. His research has focused on innovative solutions to complex biological problems, showcasing his expertise in the field.

Collaborations

Throughout his career, Gnanasekaran has collaborated with notable colleagues, including Richard A. Bunce and Mario Rivera. These collaborations have further enriched his research and contributed to the advancement of his inventions.

Conclusion

Krishna Kumar Gnanasekaran's innovative work in bioengineering and his numerous patents highlight his commitment to addressing critical challenges in healthcare. His contributions are paving the way for new treatments and methods to combat bacterial infections effectively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…